Zelniker TA, Bonaca MP, Furtado R, Mosenzon O, et al. Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes
Mellitus: Insights from the DECLARE-TIMI 58 Trial. Circulation 2020 Jan 27. doi: 10.1161/CIRCULATIONAHA.119.044183.
PMID: 31983236